Outcomes of Severe Sepsis and Septic Shock Patients on Chronic Antiplatelet Treatment: A Historical Cohort Study

Background. Sepsis is characterized by dysfunctional activation of platelets, and antiplatelet therapy could improve the outcomes of septic patients. Methods. We performed a retrospective cohort study of severe sepsis or septic shock adult patients. Outcomes of patients on antiplatelet therapy were...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan C. Valerio-Rojas, Insara J. Jaffer, Daryl J. Kor, Ognjen Gajic, Rodrigo Cartin-Ceba
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Critical Care Research and Practice
Online Access:http://dx.doi.org/10.1155/2013/782573
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556027153743872
author Juan C. Valerio-Rojas
Insara J. Jaffer
Daryl J. Kor
Ognjen Gajic
Rodrigo Cartin-Ceba
author_facet Juan C. Valerio-Rojas
Insara J. Jaffer
Daryl J. Kor
Ognjen Gajic
Rodrigo Cartin-Ceba
author_sort Juan C. Valerio-Rojas
collection DOAJ
description Background. Sepsis is characterized by dysfunctional activation of platelets, and antiplatelet therapy could improve the outcomes of septic patients. Methods. We performed a retrospective cohort study of severe sepsis or septic shock adult patients. Outcomes of patients on antiplatelet therapy were compared to those that were not taking antiplatelet therapy by univariate analysis followed by a propensity score analysis based on the probability of receiving antiplatelet therapy. Results. Of 651 patients included in the study 272 (42.8%) were on antiplatelet therapy before the development of severe sepsis or septic shock. After adjusting for important confounding variables antiplatelet therapy was not associated with a decreased risk of hospital mortality (odds ratio 0.73, 95% confidence interval 0.46–1.16). Antiplatelet therapy was associated with a decreased incidence of acute respiratory distress syndrome/acute lung injury (odds ratio 0.50, 95% confidence interval 0.35–0.71) and reduced need of mechanical ventilation (odds ratio 0.62, 95% confidence interval 0.45–87). Incidence of acute kidney injury was similar between both groups (odds ratio 1.08, 95% confidence interval 0.73–1.59). Conclusions. The use of antiplatelet therapy before the diagnosis of severe sepsis or septic shock was not associated with decreased hospital mortality. Antiplatelet therapy was associated with a decreased incidence of acute lung injury/acute respiratory distress syndrome.
format Article
id doaj-art-e7bae7ead2e64a8781bb5fd211bcf0fb
institution Kabale University
issn 2090-1305
2090-1313
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Critical Care Research and Practice
spelling doaj-art-e7bae7ead2e64a8781bb5fd211bcf0fb2025-02-03T05:46:34ZengWileyCritical Care Research and Practice2090-13052090-13132013-01-01201310.1155/2013/782573782573Outcomes of Severe Sepsis and Septic Shock Patients on Chronic Antiplatelet Treatment: A Historical Cohort StudyJuan C. Valerio-Rojas0Insara J. Jaffer1Daryl J. Kor2Ognjen Gajic3Rodrigo Cartin-Ceba4Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC), Mayo Clinic, Rochester, MN 55905, USAMultidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC), Mayo Clinic, Rochester, MN 55905, USAMultidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC), Mayo Clinic, Rochester, MN 55905, USAMultidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC), Mayo Clinic, Rochester, MN 55905, USAMultidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC), Mayo Clinic, Rochester, MN 55905, USABackground. Sepsis is characterized by dysfunctional activation of platelets, and antiplatelet therapy could improve the outcomes of septic patients. Methods. We performed a retrospective cohort study of severe sepsis or septic shock adult patients. Outcomes of patients on antiplatelet therapy were compared to those that were not taking antiplatelet therapy by univariate analysis followed by a propensity score analysis based on the probability of receiving antiplatelet therapy. Results. Of 651 patients included in the study 272 (42.8%) were on antiplatelet therapy before the development of severe sepsis or septic shock. After adjusting for important confounding variables antiplatelet therapy was not associated with a decreased risk of hospital mortality (odds ratio 0.73, 95% confidence interval 0.46–1.16). Antiplatelet therapy was associated with a decreased incidence of acute respiratory distress syndrome/acute lung injury (odds ratio 0.50, 95% confidence interval 0.35–0.71) and reduced need of mechanical ventilation (odds ratio 0.62, 95% confidence interval 0.45–87). Incidence of acute kidney injury was similar between both groups (odds ratio 1.08, 95% confidence interval 0.73–1.59). Conclusions. The use of antiplatelet therapy before the diagnosis of severe sepsis or septic shock was not associated with decreased hospital mortality. Antiplatelet therapy was associated with a decreased incidence of acute lung injury/acute respiratory distress syndrome.http://dx.doi.org/10.1155/2013/782573
spellingShingle Juan C. Valerio-Rojas
Insara J. Jaffer
Daryl J. Kor
Ognjen Gajic
Rodrigo Cartin-Ceba
Outcomes of Severe Sepsis and Septic Shock Patients on Chronic Antiplatelet Treatment: A Historical Cohort Study
Critical Care Research and Practice
title Outcomes of Severe Sepsis and Septic Shock Patients on Chronic Antiplatelet Treatment: A Historical Cohort Study
title_full Outcomes of Severe Sepsis and Septic Shock Patients on Chronic Antiplatelet Treatment: A Historical Cohort Study
title_fullStr Outcomes of Severe Sepsis and Septic Shock Patients on Chronic Antiplatelet Treatment: A Historical Cohort Study
title_full_unstemmed Outcomes of Severe Sepsis and Septic Shock Patients on Chronic Antiplatelet Treatment: A Historical Cohort Study
title_short Outcomes of Severe Sepsis and Septic Shock Patients on Chronic Antiplatelet Treatment: A Historical Cohort Study
title_sort outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment a historical cohort study
url http://dx.doi.org/10.1155/2013/782573
work_keys_str_mv AT juancvaleriorojas outcomesofseveresepsisandsepticshockpatientsonchronicantiplatelettreatmentahistoricalcohortstudy
AT insarajjaffer outcomesofseveresepsisandsepticshockpatientsonchronicantiplatelettreatmentahistoricalcohortstudy
AT daryljkor outcomesofseveresepsisandsepticshockpatientsonchronicantiplatelettreatmentahistoricalcohortstudy
AT ognjengajic outcomesofseveresepsisandsepticshockpatientsonchronicantiplatelettreatmentahistoricalcohortstudy
AT rodrigocartinceba outcomesofseveresepsisandsepticshockpatientsonchronicantiplatelettreatmentahistoricalcohortstudy